As per terms of the deal, Roche will secure worldwide and exclusive license from GO Therapeutics for cancer-specific targeting antibodies. The license will allow Roche to develop and
The post Cancer startup GO Therapeutics signs $195m licensing deal with Roche appeared first on Pharma Business review.
Original Article: Cancer startup GO Therapeutics signs $195m licensing deal with Roche